Cargando…
The Hepatorenal Syndrome Patient Pathway: Retrospective Analysis of Electronic Health Records
BACKGROUND: Hepatorenal syndrome (HRS) is among the leading causes of hospitalization and mortality in patients with chronic liver disease. OBJECTIVE: To assess the HRS patient journey from preadmission to postdischarge to understand patient characteristics, disease progression, treatment patterns,...
Autores principales: | Jamil, Khurram, Huang, Xingyue, Hayashida, David, Lodaya, Kunal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987804/ https://www.ncbi.nlm.nih.gov/pubmed/35399809 http://dx.doi.org/10.1016/j.curtheres.2022.100663 |
Ejemplares similares
-
Real‐world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome
por: Moore, Kevin, et al.
Publicado: (2020) -
The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome
por: Velez, Juan Carlos Q., et al.
Publicado: (2023) -
ML2 Supervised Machine Learning Predicts Mortality in COVID-19 Patients Using Electronic Health Records
por: Marinaro, X., et al.
Publicado: (2021) -
Role of Terlipressin in Patients With Hepatorenal Syndrome-Acute Kidney Injury Admitted to the ICU: A Substudy of the CONFIRM Trial
por: Karvellas, Constantine J., et al.
Publicado: (2023) -
Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndrome
por: Wong, Florence, et al.
Publicado: (2019)